3786
R. Fischer et al.
PAPER
2-Benzyl-3-phenyl-2,3-dihydroisoxazole (10); Typical Proce-
dure
4.19 (d, J = 12.9 Hz, 1 H, NCH2Ph), 4.78 (dd, J = 2.3, 2.9 Hz, 1 H,
H4), 6.54–6.56 (m, 1 H, H5), 7.26–7.39 (m, 5 H, Ph).
The reaction flask was charged with 5-acetoxyisoxazolidine 5 (1.5
g, 5.0 mmol), sealed with a rubber septum, and filled with argon.
Anhyd NMP (25 mL) was added followed by BSTFA (1.59 mL, 6.0
mmol). The soln was cooled in an ice/water bath (2–5 °C) and
TMSOTf (0.09 mL, 0.5 mmol) was added. The mixture was subse-
quently stirred at r.t. for 3 h in the dark. When the initial 5-
acetoxyisoxazolidine had been consumed (TLC, hexanes–EtOAc,
83:17), the mixture was cooled in an ice/water bath, sat. aq NaHCO3
(30 mL) and Et2O (50 mL) were added, and the mixture was stirred
for 5 min. The precipitated solid was dissolved by addition of H2O
(50 mL). The aqueous layer was removed, the organic layer was
washed with H2O (3 × 30 mL) and dried (Na2SO4), and the solvent
was evaporated in vacuo (bath temperature < 35 °C). 2,3-Dihy-
droisoxazole 10 was isolated by column chromatography (silica gel,
hexanes–EtOAc, 90:10) as a colorless oil that became darker over
time; yield: 0.89 g (3.75 mmol, 75%).
13C NMR (150.8 MHz, CDCl3): δ = 25.1, 26.3, 63.3, 65.5, 70.7,
77.5, 94.9, 109.3, 127.6, 128.4, 129.5, 135.9, 143.9.
Anal. Calcd for C15H19NO3: C, 68.94; H, 7.33; N, 5.36. Found: C,
69.08; H, 7.10; N, 5.09.
(3S)-2-Benzyl-3-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl)]-2,3-di-
hydroisoxazole (11b)
Colorless solid; yield: 385 mg (52%); mp 42–43 °C; [α]D20 –265.73
(c 1.02, CHCl3).
1H NMR (600 MHz, CDCl3): δ = 1.31, 1.38 [2 s, 2 × 3 H, C(CH3)2],
3.50–3.53 (m, 1 H, H2a′), 3.82 (d, J = 12.9 Hz, 1 H, NCH2Ph), 3.89–
3.91 (m, 1 H, H3), 3.92–3.97 (m, 2 H, H1′, H2b′), 4.15 (d, J = 12.9
Hz, 1 H, NCH2Ph), 5.00 (dd, J = 2.3, 2.9 Hz, 1 H, H4), 6.51–6.53
(m, 1 H, H5), 7.25–7.38 (m, 5 H, Ph).
13C NMR (150.8 MHz, CDCl3): δ = 25.3, 26.7, 63.3, 66.8, 70.6,
78.6, 97.1, 109.3, 127.8, 128.4, 129.5, 136.1, 143.2.
1H NMR (600 MHz, CDCl3): δ = 4.02 (d, J = 12.9 Hz, 1 H,
NCH2Ph), 4.30 (d, J = 12.9 Hz, 1 H, NCH2Ph), 4.90–4.92 (m, 1 H,
H3), 5.01 (dd, J = 2.3, 2.9 Hz, 1 H, H4), 6.56–6.58 (m, 1 H, H5),
7.20–7.40 (m, 10 H, Ph).
Anal. Calcd for C15H19NO3: C, 68.94; H, 7.33; N, 5.36. Found: C,
68.76; H 7.06; N 5.12.
13C NMR (150.8 MHz, CDCl3): δ = 63.3, 72.1, 100.1, 127.0, 127.5
(2 C), 128.3, 128.5, 129.3, 136.5 (2 C), 142.0.
(3S)-2-Benzyl-3-(1,2:3,4-di-O-isopropylidene-D-xylo-tetritol-1-
yl)-2,3-dihydroisoxazole (12b)
Colorless viscous oil, becomes darker over time; yield: 215 mg
20
Anal. Calcd for C16H15NO: C, 80.98; H, 6.37; N, 5.90. Found: C,
80.91; H, 6.14; N, 6.19.
(50%); [α]D –166.66 (c 1.03, CHCl3). Additionally, a mixture of
unseparated isomers 12a and 12b (100 mg, 23%) was also isolated.
1H NMR (600 MHz, CDCl3): δ = 1.35, 1.37, 1.39, 1.40 [4 s, 4 × 3
H, C(CH3)2], 3.63 (dd, J = 4.1, 7.0 Hz, 1 H, H2′), 3.85 (d, J = 12.9
Hz, 1 H, NCH2Ph), 3.85 (dd, J = 7.0, 6.5 Hz, 1 H, H1′), 3.88–3.94
(m, 2 H, H4′), 4.04 (td, J = 1.8, 2.3 Hz, 1 H, H3), 4.12 (dt, J = 7.0,
4.1 Hz, 1 H, H3′), 4.16 (d, J = 12.9 Hz, 1 H, NCH2Ph), 5.00 (dd, J =
2.3, 2.9 Hz, 1 H, H4), 6.52–6.54 (m, 1 H, H5), 7.28–7.38 (m, 5 H,
Ph).
13C NMR (150.8 MHz, CDCl3): δ = 25.8, 26.3, 27.1, 27.5, 63.3,
66.0, 70.5, 76.3, 78.6, 79.6, 96.7, 109.5, 109.6, 127.8, 128.5, 129.6,
135.9, 143.4.
(3S)-3-(3-O-Benzoyl-4-O-tert-butyldiphenylsilyl-1,2-O-isopro-
pylidene-D-xylo-tetritol-1-yl)-2-benzyl-2,3-dihydroisoxazole (3)
Colorless oil, becomes darker over time; yield: 200 mg (73%);
[α]D20 –84.64 (c 0.86, CHCl3).
1H NMR (600 MHz, CDCl3): δ = 0.96 [s, 9 H, OSiC(CH3)3], 1.39,
1.41 [2 s, 2 × 3 H, C(CH3)2], 3.84 (dd, J = 4.1, 7.6, 1 H, H1′), 3.87
(dd, J = 5.3, 10.6 Hz, 1 H, H4a′), 3.92 (d, J = 13.5 Hz, 1 H,
NCH2Ph), 3.95 (dd, J = 8.2, 10.6 Hz, 1 H, H4b′), 4.15 (d, J = 13.5
Hz, 1 H, NCH2Ph), 4.18–4.20 (m, 1 H, H3), 4.29 (dd, J = 1.8, 7.6
Hz, 1 H, H2′), 4.94 (dd, J = 2.3, 2.9 Hz, 1 H, H4), 5.49 (ddd, J = 5.3,
8.2, 1.8 Hz, 1 H, H3′), 6.45–6.47 (m, 1 H, H5), 7.23–7.41 (m, 11 H,
Ph), 7.44 (t, 2 H, Ph), 7.56 (t, 1 H, Ph), 7.62 (d, 2 H, Ph), 7.67 (d, 2
H, Ph), 8.09 (d, 2 H, Ph).
Anal. Calcd for C20H27NO5: C, 66.46; H, 7.53; N, 3.88. Found: C,
66.23; H, 7.48; N, 3.63.
13C NMR (150.8 MHz, CDCl3): δ = 19.1, 26.6, 27.1, 27.3, 63.4,
64.0, 70.0, 73.2, 76.1, 78.1, 95.6, 109.4, 127.5, 127.6 (2 C), 128.3
(2 C), 129.1, 129.6 (2 C), 129.8, 130.2, 133.0, 133.3, 133.4, 135.6
(2 C), 136.6, 143.5, 166.0.
Ethyl 2-Benzyl-5-(2-oxooxazolidin-3-yl)isoxazolidine-3-carbox-
ylate (18)
The reaction flask was charged with the 5-acetoxyisoxazolidine 4
(150 mg, 0.51 mmol), sealed with a rubber septum and filled with
argon. Anhyd DCE was added (0.50 mL) followed by N-(trimethyl-
silyl)oxazolidin-2-one (17, 0.12 mL, 0.76 mmol). The soln was
cooled in an ice/water bath (2–5 °C) and TMSOTf (10 μL, 0.05
mmol) was added. The mixture was subsequently stirred at r.t. for
24 h. When the initial 5-acetoxyisoxazolidine had been consumed
(TLC, hexanes–EtOAc, 40:60), the mixture was cooled in an
ice/water bath, sat. aq NaHCO3 (5 mL) and CH2Cl2 (5 mL) were
added, and the mixture was stirred for 5 min. The aqueous layer was
removed and extracted with CH2Cl2 (5 mL). The combined organic
layers were washed with H2O and dried (Na2SO4), and the solvent
was evaporated in vacuo. The products were separated by column
chromatography (silica gel, hexanes–EtOAc, 40:60).
Anal. Calcd for C40H45NO6Si: C, 72.37; H, 6.83; N, 2.11. Found: C,
72.65; H, 7.09; N, 2.32.
Ethyl 2-Benzyl-2,3-dihydroisoxazole-3-carboxylate (9)
Colorless oil, becomes darker over time; yield: 610 mg (76%).
1H NMR (600 MHz, CDCl3): δ = 1.23 (t, J = 7.3 Hz, 3 H,
OCH2CH3), 3.97 (d, J = 13.0 Hz, 1 H, NCH2Ph), 4.16 (q, J = 7.3 Hz,
2 H, OCH2CH3), 4.29 (d, J = 13.0 Hz, 1 H, NCH2Ph), 4.48 (dd, J =
2.4, 2.8 Hz, 1 H, H3), 4.94 (dd, J = 2.4, 2.8 Hz, 1 H, H4), 6.55–6.57
(m, 1 H, H5), 7.28–7.41 (m, 5 H, Ph).
13C NMR (150.8 MHz, CDCl3): δ = 14.1, 61.3, 63.4, 70.1, 94.8,
127.8, 128.5, 129.3, 135.4, 143.8, 170.4.
3,5-cis-18a
Anal. Calcd for C13H15NO3: C, 66.94; H, 6.48; N, 6.00. Found: C,
66.99; H, 6.21; N, 6.27.
Colorless oil; yield: 33 mg (0.1 mmol, 20%).
1H NMR (300 MHz, CDCl3): δ = 1.25 (t, J = 7.0 Hz, 3 H,
OCH2CH3), 2.57 (ddd, J = 4.1, 7.6, 13.8 Hz, 1 H, H4a), 2.87 (ddd,
J = 8.2, 9.1, 13.8 Hz, 1 H, H4b), 3.55 (dd, J = 7.6, 9.1 Hz, 1 H, H3),
3.69–3.90 (m, 2 H, NCH2CH2O), 4.01 (d, J = 13.5 Hz, 1 H,
NCH2Ph), 4.09–4.16 (m, 2 H, OCH2CH3), 4.13 (d, J = 13.5 Hz, 1 H,
NCH2Ph), 4.22–4.35 (m, 2 H, NCH2CH2O), 5.92 (dd, J = 4.1, 8.2
Hz, 1 H, H5), 7.27–7.36 (m, 5 H, Ph).
(3R)-2-Benzyl-3-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl)]-2,3-di-
hydroisoxazole (11a)
Colorless solid; yield: 130 mg (18%); mp 47–48 °C; [α]D20 +262.49
(c 1.01, CHCl3).
1H NMR (600 MHz, CDCl3): δ = 1.30, 1.31 [2 s, 2 × 3 H, C(CH3)2],
3.71 (dd, J = 8.8, 11.2 Hz, 1 H, H2a′), 3.89 (d, J = 12.9 Hz, 1 H,
NCH2Ph), 3.98–4.01 (m, 2 H, H1′, H2b′), 4.06–4.07 (m, 1 H, H3),
13C NMR (75.4 MHz, CDCl3): δ = 14.1, 36.3, 40.9, 61.6, 61.7, 62.4,
66.7, 81.6, 127.7, 128.3, 129.2, 135.9, 157.7, 169.9.
Synthesis 2012, 44, 3783–3788
© Georg Thieme Verlag Stuttgart · New York